Chemomab Therapeutics Market Sentiment

Chemomab Therapeutics Ltd

CMMBNASDAQ

$1.13

0.032.73%

Últ. Act.: Oct 29, 9:39 AM

Chemomab Therapeutics Market Sentiment - Benzinga

Market sentiment signals for Chemomab Therapeutics (CMMB): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 0.2% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

3 analysts

Options Flow (P/C)

—

Avg Consensus PT

$27

+2289.4%

Highest Price Target

$28

+2377.9%

Roth MKM

Lowest Price Target

$25

+2112.4%

Oppenheimer

Short Interest

0.2%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 27, 2025	Oppenheimer	Jeff Jones—	+2112.4%	$10 → $25	Maintained	Outperform
May 16, 2025	Oppenheimer	Jeff Jones—	+3439.8%	$44 → $40	Maintained	Outperform
Feb 20, 2025	Maxim Group	Michael Okunewitch—	+2377.9%	$16 → $28	Maintained	Buy
Nov 15, 2024	Oppenheimer	Jeff Jones—	+3793.8%	$52 → $44	Maintained	Outperform
May 13, 2024	Maxim Group	Michael Okunewitch—	+1315.9%	$16	Initiate	Buy
May 6, 2024	Oppenheimer	Jeff Jones—	+2023.9%	$24	Upgrade	Perform→Outperform
Mar 8, 2024	Oppenheimer	Jeff Jones—	—	—	Maintained	Perform
Dec 19, 2023	Roth MKM	Dylan Dupuis—	+2377.9%	$28 → $28	Reinstates	Buy